CHD8 is an independent prognostic indicator that regulates Wnt/β-catenin signaling and the cell cycle in gastric cancer

Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin. 54:8–29. 2004. View Article : Google Scholar

Marfella CG and Imbalzano AN: The Chd family of chromatin remodelers. Mutat Res. 618:30–40. 2007. View Article : Google Scholar : PubMed/NCBI

Lusser A and Kadonaga JT: Chromatin remodeling by ATP-dependent molecular machines. Bioessays. 25:1192–1200. 2003. View Article : Google Scholar : PubMed/NCBI

Tsukiyama T: The in vivo functions of ATP-dependent chromatin-remodelling factors. Nat Rev Mol Cell Biol. 3:422–429. 2002. View Article : Google Scholar : PubMed/NCBI

Hall JA and Georgel PT: CHD proteins: a diverse family with Strong Ties. Biochem Cell Biol. 85:463–476. 2007.PubMed/NCBI

Pleasance ED, Stephens PJ, O’Meara S, et al: A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature. 463:184–190. 2010. View Article : Google Scholar : PubMed/NCBI

Bagchi A, Papazoglu C, Wu Y, et al: CHD5 is a tumor suppressor at human 1p36. Cell. 128:459–475. 2007. View Article : Google Scholar : PubMed/NCBI

Thompson BA, Tremblay V, Lin G and Bochar DA: CHD8 is an ATP-dependent chromatin remodeling factor that regulates β-catenin target genes. Mol Cell Biol. 28:3894–3904. 2008.PubMed/NCBI

Sakamoto I, Kishida S, Fukui A, et al: A novel β-catenin-binding protein inhibits β-catenin-dependent Tcf activation and axis formation. J Biol Chem. 275:32871–32878. 2000.

Yates JA, Menon T, Thompson BA and Bochar DA: Regulation of HOXA2 gene expression by the ATP-dependent chromatin remodeling enzyme CHD8. FEBS Lett. 584:689–693. 2010. View Article : Google Scholar : PubMed/NCBI

Rodríguez-Paredes M, Ceballos-Chávez M, Esteller M, García-Domínguez M and Reyes JC: The chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 gene. Nucleic Acids Res. 37:2449–2460. 2009.PubMed/NCBI

Rodenberg JM, Hoggatt AM, Chen M, Touw K, Jones R and Herring BP: Regulation of serum response factor activity and smooth muscle cell apoptosis by chromodomain helicase DNA-binding protein 8. Am J Physiol Cell Physiol. 299:C1058–C1067. 2010. View Article : Google Scholar : PubMed/NCBI

Yuan CC, Zhao X, Florens L, Swanson SK, Washburn MP and Hernandez N: CHD8 associates with human Staf and contributes to efficient U6 RNA polymerase III transcription. Mol Cell Biol. 27:8729–8738. 2007. View Article : Google Scholar : PubMed/NCBI

Menon T, Yates JA and Bochar DA: Regulation of androgen-responsive transcription by the chromatin remodeling factor CHD8. Mol Endocrinol. 24:1165–1174. 2010. View Article : Google Scholar : PubMed/NCBI

Nishiyama M, Oshikawa K, Tsukada Y, et al: CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis. Nat Cell Biol. 11:172–182. 2009. View Article : Google Scholar : PubMed/NCBI

Nishiyama M, Skoultchi AI and Nakayama KI: Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-β-catenin signaling pathway. Mol Cell Biol. 32:501–512. 2012.PubMed/NCBI

Bienz M and Clevers H: Linking colorectal cancer to Wnt signaling. Cell. 103:311–320. 2000. View Article : Google Scholar : PubMed/NCBI

Moon RT, Kohn AD, De Ferrari GV and Kaykas A: WNT and β-catenin signalling: diseases and therapies. Nat Rev Genet. 5:691–701. 2004.

Nelson WJ and Nusse R: Convergence of Wnt, β-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.

Willert K and Jones KA: Wnt signaling: is the party in the nucleus? Genes Dev. 20:1394–1404. 2006. View Article : Google Scholar : PubMed/NCBI

Ooi CH, Ivanova T, Wu J, et al: Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 5:e10006762009. View Article : Google Scholar : PubMed/NCBI